NRG GY017 Anti-PD-L1 (Azetolizumab) as an Immune Primer and Concurrently with EFRT for Node Positive Locally Advanced Cervical Cancer (33) NCT03738228. The gene discussed is CD274; the disease is cervical carcinoma.